Milestone Scientific (MLSS) Competitors

$0.39 0.00 (0.00%)

Closing price 04:00 PM Eastern

Extended Trading

$0.39 +0.00 (+0.77%)

As of 05:48 PM Eastern

MLSS vs. HSDT, NNOX, FONR, MBOT, and NYXH

Should you buy Milestone Scientific stock or one of its competitors? MarketBeat compares Milestone Scientific with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Milestone Scientific include Solana (HSDT), Nano-X Imaging (NNOX), Fonar (FONR), Microbot Medical (MBOT), and Nyxoah (NYXH). These companies are all part of the "medical equipment" industry.

How does Milestone Scientific compare to Solana?

Milestone Scientific (NYSE:MLSS) and Solana (NASDAQ:HSDT) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, risk, analyst recommendations, media sentiment, profitability, valuation and dividends.

Milestone Scientific currently has a consensus target price of $1.00, indicating a potential upside of 156.41%. Solana has a consensus target price of $3.50, indicating a potential upside of 136.49%. Given Milestone Scientific's stronger consensus rating and higher probable upside, equities analysts plainly believe Milestone Scientific is more favorable than Solana.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Milestone Scientific	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Solana	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

Milestone Scientific has a beta of 1.04, suggesting that its share price is 4% more volatile than the broader market. Comparatively, Solana has a beta of 1.06, suggesting that its share price is 6% more volatile than the broader market.

5.8% of Milestone Scientific shares are held by institutional investors. Comparatively, 18.6% of Solana shares are held by institutional investors. 12.5% of Milestone Scientific shares are held by insiders. Comparatively, 14.4% of Solana shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Milestone Scientific has a net margin of -52.01% compared to Solana's net margin of -1,427.15%. Milestone Scientific's return on equity of -60.26% beat Solana's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Milestone Scientific	-52.01%	-60.26%	-40.23%
Solana	-1,427.15%	-67.57%	-24.09%

Milestone Scientific has higher revenue and earnings than Solana. Milestone Scientific is trading at a lower price-to-earnings ratio than Solana, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Milestone Scientific	$8.90M	3.86	-$6.93M	-$0.05	N/A
Solana	$6.02M	14.36	-$40.89M	-$109.67	N/A

In the previous week, Milestone Scientific and Milestone Scientific both had 1 articles in the media. Solana's average media sentiment score of 1.13 beat Milestone Scientific's score of 0.67 indicating that Solana is being referred to more favorably in the news media.

Company	Overall Sentiment
Milestone Scientific	Positive
Solana	Positive

Summary

Solana beats Milestone Scientific on 8 of the 15 factors compared between the two stocks.

How does Milestone Scientific compare to Nano-X Imaging?

Milestone Scientific (NYSE:MLSS) and Nano-X Imaging (NASDAQ:NNOX) are both small-cap medical equipment companies, but which is the better business? We will compare the two businesses based on the strength of their risk, media sentiment, valuation, institutional ownership, earnings, dividends, profitability and analyst recommendations.

Milestone Scientific presently has a consensus target price of $1.00, suggesting a potential upside of 156.41%. Nano-X Imaging has a consensus target price of $5.00, suggesting a potential upside of 167.38%. Given Nano-X Imaging's higher probable upside, analysts clearly believe Nano-X Imaging is more favorable than Milestone Scientific.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Milestone Scientific	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Nano-X Imaging	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	3 Strong Buy rating(s)	2.83

Milestone Scientific has higher earnings, but lower revenue than Nano-X Imaging. Milestone Scientific is trading at a lower price-to-earnings ratio than Nano-X Imaging, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Milestone Scientific	$8.90M	3.86	-$6.93M	-$0.05	N/A
Nano-X Imaging	$13.02M	9.99	-$75.02M	-$1.59	N/A

Milestone Scientific has a beta of 1.04, indicating that its share price is 4% more volatile than the broader market. Comparatively, Nano-X Imaging has a beta of 1.21, indicating that its share price is 21% more volatile than the broader market.

Milestone Scientific has a net margin of -52.01% compared to Nano-X Imaging's net margin of -790.87%. Milestone Scientific's return on equity of -60.26% beat Nano-X Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Milestone Scientific	-52.01%	-60.26%	-40.23%
Nano-X Imaging	-790.87%	-64.65%	-57.27%

In the previous week, Nano-X Imaging had 2 more articles in the media than Milestone Scientific. MarketBeat recorded 3 mentions for Nano-X Imaging and 1 mentions for Milestone Scientific. Milestone Scientific's average media sentiment score of 0.67 beat Nano-X Imaging's score of 0.63 indicating that Milestone Scientific is being referred to more favorably in the media.

Company	Overall Sentiment
Milestone Scientific	Positive
Nano-X Imaging	Positive

5.8% of Milestone Scientific shares are held by institutional investors. Comparatively, 21.5% of Nano-X Imaging shares are held by institutional investors. 12.5% of Milestone Scientific shares are held by insiders. Comparatively, 7.7% of Nano-X Imaging shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Milestone Scientific and Nano-X Imaging tied by winning 8 of the 16 factors compared between the two stocks.

How does Milestone Scientific compare to Fonar?

Milestone Scientific (NYSE:MLSS) and Fonar (NASDAQ:FONR) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, valuation, profitability, media sentiment, analyst recommendations, earnings, institutional ownership and dividends.

Milestone Scientific has a beta of 1.04, meaning that its stock price is 4% more volatile than the broader market. Comparatively, Fonar has a beta of 0.95, meaning that its stock price is 5% less volatile than the broader market.

Fonar has a net margin of 6.35% compared to Milestone Scientific's net margin of -52.01%. Fonar's return on equity of 4.12% beat Milestone Scientific's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Milestone Scientific	-52.01%	-60.26%	-40.23%
Fonar	6.35%	4.12%	3.07%

In the previous week, Fonar had 9 more articles in the media than Milestone Scientific. MarketBeat recorded 10 mentions for Fonar and 1 mentions for Milestone Scientific. Fonar's average media sentiment score of 1.25 beat Milestone Scientific's score of 0.67 indicating that Fonar is being referred to more favorably in the news media.

Company	Overall Sentiment
Milestone Scientific	Positive
Fonar	Positive

Fonar has higher revenue and earnings than Milestone Scientific. Milestone Scientific is trading at a lower price-to-earnings ratio than Fonar, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Milestone Scientific	$8.90M	3.86	-$6.93M	-$0.05	N/A
Fonar	$104.35M	1.13	$8.33M	$1.00	19.08

5.8% of Milestone Scientific shares are owned by institutional investors. Comparatively, 50.6% of Fonar shares are owned by institutional investors. 12.5% of Milestone Scientific shares are owned by company insiders. Comparatively, 7.9% of Fonar shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Milestone Scientific currently has a consensus target price of $1.00, suggesting a potential upside of 156.41%. Given Milestone Scientific's stronger consensus rating and higher possible upside, equities research analysts clearly believe Milestone Scientific is more favorable than Fonar.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Milestone Scientific	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Fonar	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Fonar beats Milestone Scientific on 10 of the 16 factors compared between the two stocks.

How does Milestone Scientific compare to Microbot Medical?

Milestone Scientific (NYSE:MLSS) and Microbot Medical (NASDAQ:MBOT) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, risk, earnings, profitability, institutional ownership, media sentiment, valuation and dividends.

Microbot Medical has a net margin of 0.00% compared to Milestone Scientific's net margin of -52.01%. Microbot Medical's return on equity of -21.84% beat Milestone Scientific's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Milestone Scientific	-52.01%	-60.26%	-40.23%
Microbot Medical	N/A	-21.84%	-20.71%

In the previous week, Microbot Medical had 1 more articles in the media than Milestone Scientific. MarketBeat recorded 2 mentions for Microbot Medical and 1 mentions for Milestone Scientific. Milestone Scientific's average media sentiment score of 0.67 beat Microbot Medical's score of 0.63 indicating that Milestone Scientific is being referred to more favorably in the media.

Company	Overall Sentiment
Milestone Scientific	Positive
Microbot Medical	Positive

Milestone Scientific currently has a consensus target price of $1.00, indicating a potential upside of 156.41%. Microbot Medical has a consensus target price of $6.63, indicating a potential upside of 236.29%. Given Microbot Medical's higher possible upside, analysts clearly believe Microbot Medical is more favorable than Milestone Scientific.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Milestone Scientific	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Microbot Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.60

Milestone Scientific has higher revenue and earnings than Microbot Medical. Milestone Scientific is trading at a lower price-to-earnings ratio than Microbot Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Milestone Scientific	$8.90M	3.86	-$6.93M	-$0.05	N/A
Microbot Medical	N/A	N/A	-$13.14M	-$0.26	N/A

5.8% of Milestone Scientific shares are owned by institutional investors. Comparatively, 16.3% of Microbot Medical shares are owned by institutional investors. 12.5% of Milestone Scientific shares are owned by company insiders. Comparatively, 4.7% of Microbot Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Milestone Scientific has a beta of 1.04, indicating that its share price is 4% more volatile than the broader market. Comparatively, Microbot Medical has a beta of 1.04, indicating that its share price is 4% more volatile than the broader market.

Summary

Microbot Medical beats Milestone Scientific on 8 of the 15 factors compared between the two stocks.

How does Milestone Scientific compare to Nyxoah?

Nyxoah (NASDAQ:NYXH) and Milestone Scientific (NYSE:MLSS) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, media sentiment, valuation, institutional ownership, earnings, profitability, risk and analyst recommendations.

Milestone Scientific has a net margin of -52.01% compared to Nyxoah's net margin of -543.21%. Milestone Scientific's return on equity of -60.26% beat Nyxoah's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nyxoah	-543.21%	-163.73%	-80.24%
Milestone Scientific	-52.01%	-60.26%	-40.23%

In the previous week, Nyxoah had 1 more articles in the media than Milestone Scientific. MarketBeat recorded 2 mentions for Nyxoah and 1 mentions for Milestone Scientific. Nyxoah's average media sentiment score of 0.94 beat Milestone Scientific's score of 0.67 indicating that Nyxoah is being referred to more favorably in the media.

Company	Overall Sentiment
Nyxoah	Positive
Milestone Scientific	Positive

Nyxoah currently has a consensus target price of $7.67, indicating a potential upside of 167.13%. Milestone Scientific has a consensus target price of $1.00, indicating a potential upside of 156.41%. Given Nyxoah's higher possible upside, equities research analysts plainly believe Nyxoah is more favorable than Milestone Scientific.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nyxoah	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Milestone Scientific	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Milestone Scientific has lower revenue, but higher earnings than Nyxoah. Milestone Scientific is trading at a lower price-to-earnings ratio than Nyxoah, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nyxoah	$11.33M	9.82	-$101.92M	-$2.48	N/A
Milestone Scientific	$8.90M	3.86	-$6.93M	-$0.05	N/A

5.8% of Milestone Scientific shares are held by institutional investors. 17.1% of Nyxoah shares are held by insiders. Comparatively, 12.5% of Milestone Scientific shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Nyxoah has a beta of 1.55, suggesting that its share price is 55% more volatile than the broader market. Comparatively, Milestone Scientific has a beta of 1.04, suggesting that its share price is 4% more volatile than the broader market.

Summary

Nyxoah beats Milestone Scientific on 9 of the 16 factors compared between the two stocks.

Get Milestone Scientific News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MLSS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MLSS vs. The Competition

Export

Metric	Milestone Scientific	Surgical appliances & supplies Industry	Medical Sector	NYSE Exchange
Market Cap	$34.35M	$24.13M	$6.47B	$23.28B
Dividend Yield	N/A	N/A	2.69%	4.06%
P/E Ratio	-5.57	14.43	22.39	31.00
Price / Sales	3.86	1.62	520.79	23.82
Price / Cash	N/A	12.80	41.34	24.93
Price / Book	3.55	1.53	9.84	4.67
Net Income	-$6.93M	-$3.92M	$3.57B	$1.07B
7 Day Performance	1.30%	13.36%	-1.16%	-0.67%
1 Month Performance	15.38%	18.13%	3.85%	0.22%
1 Year Performance	-57.61%	-29.67%	27.40%	25.44%

Milestone Scientific Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MLSS Milestone Scientific	1.6013 of 5 stars	$0.39 flat	$1.00 +156.4%	-58.5%	$34.35M	$8.90M	N/A	30	Gap Down
HSDT Solana	3.3475 of 5 stars	$2.29 -3.0%	$3.50 +52.8%	-99.1%	$133.71M	$9.59M	N/A	30	Positive News
NNOX Nano-X Imaging	3.4493 of 5 stars	$1.84 -3.7%	$5.00 +171.7%	-63.3%	$128.05M	$13.02M	N/A	190
FONR Fonar	2.9795 of 5 stars	$18.90 -0.2%	N/A	+31.7%	$116.64M	$104.35M	18.90	480	Positive News
MBOT Microbot Medical	2.5259 of 5 stars	$1.71 -3.9%	$7.50 +338.6%	-24.7%	$114.85M	N/A	N/A	20	Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:MLSS) was last updated on 6/3/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Milestone Scientific (MLSS) Competitors

MLSS vs. HSDT, NNOX, FONR, MBOT, and NYXH

How does Milestone Scientific compare to Solana?

Summary

How does Milestone Scientific compare to Nano-X Imaging?

Summary

How does Milestone Scientific compare to Fonar?

Summary

How does Milestone Scientific compare to Microbot Medical?

Summary

How does Milestone Scientific compare to Nyxoah?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MLSS vs. The Competition

Milestone Scientific Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Milestone Scientific (MLSS) Competitors

MLSS vs. HSDT, NNOX, FONR, MBOT, and NYXH

How does Milestone Scientific compare to Solana?

Do analysts rate MLSS or HSDT?

Which has more risk and volatility, MLSS or HSDT?

Do insiders and institutionals have more ownership in MLSS or HSDT?

Is MLSS or HSDT more profitable?

Which has preferable valuation & earnings, MLSS or HSDT?

Does the media prefer MLSS or HSDT?

Summary

How does Milestone Scientific compare to Nano-X Imaging?

Do analysts recommend MLSS or NNOX?

Which has better earnings & valuation, MLSS or NNOX?

Which has more risk and volatility, MLSS or NNOX?

Is MLSS or NNOX more profitable?

Does the media refer more to MLSS or NNOX?

Do insiders & institutionals hold more shares of MLSS or NNOX?

Summary

How does Milestone Scientific compare to Fonar?

Which has more volatility & risk, MLSS or FONR?

Is MLSS or FONR more profitable?

Does the media favor MLSS or FONR?

Which has higher valuation & earnings, MLSS or FONR?

Do institutionals & insiders hold more shares of MLSS or FONR?

Do analysts prefer MLSS or FONR?

Summary

How does Milestone Scientific compare to Microbot Medical?

Is MLSS or MBOT more profitable?

Does the media prefer MLSS or MBOT?

Do analysts rate MLSS or MBOT?

Which has preferable earnings and valuation, MLSS or MBOT?

Do insiders and institutionals believe in MLSS or MBOT?

Which has more volatility & risk, MLSS or MBOT?

Summary

How does Milestone Scientific compare to Nyxoah?

Is NYXH or MLSS more profitable?

Does the media refer more to NYXH or MLSS?

Do analysts prefer NYXH or MLSS?

Which has higher earnings & valuation, NYXH or MLSS?

Do insiders and institutionals believe in NYXH or MLSS?

Which has more volatility and risk, NYXH or MLSS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MLSS vs. The Competition

Milestone Scientific Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools